Articles related to HEALTH OUTCOMES

This study underscores the potential of IV ketamine in managing major depressive disorder, especially in patients with a history of multiple antidepressant trials. With a significant percentage achieving response or remission within six weeks, and these benefits sustained over months, ketamine offers a promising avenue for chronic depression management.

In an insightful study on major depressive disorder, it was found that an increase in guideline concordance, as measured by the GCA-8 score, was associated with a notable improvement in patient-reported depression symptoms, emphasizing the need for rigorous adherence to established treatment protocols.

Emerging studies reveal a nuanced view of the physician’s age in relation to patient care outcomes, with evidence suggesting younger physicians may more readily employ modern competencies like evidence-based practice.

Sofia Ramiro, consultant rheumatologist and senior researcher, Leiden University Medical Center and Zuyderland Medical Center, Netherlands, presented this abstract at the ACR Convergence meeting in late 2023.

Explore the nuanced relationship between exercise and longevity and discover why a balanced lifestyle might be the real key to a longer, healthier life.

The study suggests that although unlicensed doses may lead to additional symptom reduction, the gains are small and come with an increased risk of adverse events.